CompletedNot a drug-phase studyProgressive MSNCT05299151

We could not find results for this trial

I know where the results are

What it found

No result found

We found no results in the registry or in papers.

This trial finished 2 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Vestibular exercises

Compared with

  • Standard neurorehabilitation exercises

What it measured

Main measures

  • 3D Gait Analysis System - pre assesment

    It will be done at the beginning of the study. An analysis session lasts nearly 2 hours per patient. Evaluation of all participants will take approximately 2 months.

    Walking and mobility
  • 3D Gait Analysis System - post assesment

    It will be done at the end of the study. An analysis session lasting nearly 2 hours per patient. Evaluation of all participants will take approximately 2 months.

    Walking and mobility

Other measures (6)

  • One Leg Standing Test - pre assesment

    It will be done at the beginning of the study. The test lasts nearly 5 minutes.

    Walking and mobility
  • One Leg Standing Test - post assessment

    It will be done at the end of the study. The test lasts nearly 5 minutes.

    Walking and mobility
  • Dizziness Handicap Inventory - pre assessment

    It will be done at the beginning of the study. The test lasts nearly 15 minutes.

    Walking and mobility
  • Dizziness Handicap Inventory - post assessment

    It will be done at the end of the study. The test lasts nearly 15 minutes.

    Walking and mobility
  • 2 Minute Walking Test - pre assessment

    It will be done at the beginning of the study. The test lasts nearly 5 minutes.

    Walking and mobility
  • 2 Minute Walking Test - post assessment

    It will be done at the end of the study. The test lasts nearly 5 minutes.

    Walking and mobility

Who could take part

Progressive MS · 25 to 60

Inclusion Criteria: * Between aged 25-60 years * Diagnosed with MS for at least 5 years * Relapsing and progressive MS according to Mc Donald criteria * EDSS score of ≤ 3.5 ≤ 6 * Modified Ashworth Scale \< 3 * Being eligible to work by a neurologist Exclusion Criteria: * Having had an MS-related attack in the 3 months before the study * Changes in medications within 6 months prior to the study * To have participated in the rehabilitation program within 1 month before the study * Serious neurological, cardiac, pulmonary, rheumatological, audiovisual, or orthopedic disorders that limit assessments and/or intervention programs

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

In the literature, the results of vestibular rehabilitation treatment applied in patients with Multiple Sclerosis (MS) have been investigated in detail under the headings such as fatigue, physical activity level, and quality of life, and its effects on walking have also been tried to be examined. However, in the studies conducted, gait assessments were made through questionnaires and timed tests, and devices that provide more objective data such as 3-dimensional gait analysis were not used. Again, the effects of vestibular rehabilitation programs on dual-task were not examined in previous studies. Therefore, the aims of our study are: 1. To determine the effect of individually designed vestibular rehabilitation exercises on the kinetic and kinematic components of walking; 2. To determine the effect of vestibular rehabilitation exercises specially designed for the person on gait parameters during cognitive and motor tasks.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jun 2022

    2. Main results due

      Mar 2024

    3. Finished

      May 2024

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error